Browsing Tag
GW Pharmaceuticals
8 posts
Cannabeginners: Cannabigerol (CBG) Explained
Get to know this “stem cell” cannabinoid.
U.K. Government Becomes Part Owner in CBD Firm
Despite delays of comprehensive medical reform, the UK government has now invested in a medical cannabis firm.
GW Pharmaceuticals Wins the Queens Prize for Innovation
The British cannabis pharmaceutical company takes home an award that demonstrates how important cannabis has been to the…
Maker of First FDA-Approved Cannabis Drug Updates Roll-out Plans
Could GW Pharmaceuticals see the same success with Sativex that they now have with Epidiolex?
GW Pharmaceuticals Files for FDA Approval After Report Confirms Success in Treating Epilepsy
GW Pharmaceuticals has chosen the perfect moment to file its cannabis-derived therapy, Epidiolex, with U.S. regulators. The New England…
High Growth Pot Stocks and Sectors to Watch in the 2nd Half of 2015
In June, the U.S. government lifted restrictions on scientific research into the medical and therapeutic benefits of marijuana,…
Setback for Sativex
Last week, UK-based GW Pharmaceuticals acknowledged that its cannabis-based oral spray, Sativex, failed a late-stage clinical trial as…
Harry’s World: The Science Of CBDs
The term CBD has been all over the media lately. Both Dr. Sanjay Gupta and the New York…